Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

M. Judith Peterschmitt, MD, Selena Freisens, MD, Audrey W Hou, PharmD, Lisa Underhill, MS, Meredith C. Foster, ScD, Sebastiaan J.M. Gaemers, MD

Blood (2018) 132 (Supplement 1): 3692.

https://doi.org/10.1182/blood-2018-99-118319

Published: 2018

Journal Articles

Safety and Tolerability of PF-04447943 across a Clinical Trial Program Including 277 Patients

Robert J Charnigo, MS, Beesan Tan, PhD, Denis Rybin, PhD, Debra D Pittman, MS, Krupa M. Sivamurthy, MBBS, MD, David Beidler, PhD, Nicholas Clarke, PhD

Blood (2017) 130 (Supplement 1): 3558.

https://doi.org/10.1182/blood.V130.Suppl_1.3558.3558

Published: 2017

Journal Articles

A Prospective Study to Evaluate the Efficacy, Safety and Response Duration of Newly Diagnosed Adult Immune Thrombocytopenia Patients Treated with Low Dose Rituximab and High Dose of Dexamethasone

Tuphan Kanti Dolai, MBBS, MD DNB, DM, Soumya Mukherjee, MBBS, MD, Prakas Kumar Mandal, MBBS, MD DM, Rajib De, MBBS, MD DM,, Prantar Chakrabarti, MBBS, MD DNB, DM

Blood (2016) 128 (22): 4921.

https://doi.org/10.1182/blood.V128.22.4921.4921

Published: 2016

Journal Articles

Clinical Characteristics of Philadelphia Positive T-Cell Lymphoid Leukemias - (de novo and blast phase CML)

Preetesh Jain, MBBS, MDDM, PhD, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD, Rashmi Kanagal-Shamanna, MD, Keyur P. Patel, MD PhD, Sara Emogene DellaSala, BS, Sherry Pierce, BSN, BA, Guillermo Garcia-Manero, MD, Gautam Borthakur, MD, Farhad Ravandi, MD, Susan M. O'Brien, MD, Jorge E. Cortes, MD

Blood (2016) 128 (22): 5436.

https://doi.org/10.1182/blood.V128.22.5436.5436

Published: 2016

Journal Articles

Nilotinib Combined with Multi-Agents Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study from a Single Center

Bingcheng Liu, MD, Ying Wang, MD, Chunlin Zhou, MDPhD, Hui Wei, MDPhD, Dong Lin, MDPhD, Wei Li, MD, Kaiqi Liu, Guangji Zhang, Shuning Wei, Yan Li, MD, Benfa Gong, Yuntao Liu, Yingchang Mi, MD PhD, Jianxiang Wang, MD

Blood (2015) 126 (23): 1301.

https://doi.org/10.1182/blood.V126.23.1301.1301

Published: 2015

Journal Articles

Safety and Clinical Activity of Atezolizumab (Anti-PDL1) in Combination with Obinutuzumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

Brian G. Till, MD, Steven I. Park, MD, Leslie L. Popplewell, MD, Andre Goy, MD, Elicia Penuel, PhD, Jeffrey M Venstrom, MD, Bo Liu, Guenter Fingerle-Rowson, MD PhD, John Byon, MD PhD, Paul Woodard, MD, M. Lia Palomba, MD

Blood (2015) 126 (23): 5104.

https://doi.org/10.1182/blood.V126.23.5104.5104

Published: 2015

Journal Articles

FEIBA™ for Patients on Direct Oral Anticoagulants Requiring Urgent Surgery

Joseph Shaw, B.Sc, Gregoire Le Gal, MDPhD, Melanie Tokessy, Nancy Cober, Elianna Saidenberg, MD, Marc Carrier, MDMSc, Lana Castellucci, MDMSc

Blood (2014) 124 (21): 4259.

https://doi.org/10.1182/blood.V124.21.4259.4259

Published: 2014

Journal Articles

Intraperitoneal Administration Of Activated Protein C Prevents Post-Surgical Adhesion Band Formation

Peyman Dinarvand, Alireza R. Rezaie, PhD

Blood (2013) 122 (21): 3581.

https://doi.org/10.1182/blood.V122.21.3581.3581

Published: 2013

Journal Articles

A Multicenter Phase II Study Of Bortezomib (VELCADE®) Combined With Rituximab For Untreated High Tumor Burden (HTB) Indolent Non-Hodgkin Lymphoma (NHL): Long-Term Follow-Up Of Outcomes and Examination Of Prognostic Factors

Andrew M Evens, DO, MSc, Mitchell R Smith, MD, PhD, Izidore S Lossos, MD, Irene Helenowski, PhD, Michael Millenson, MD, Jane N. Winter, MD, Steven T. Rosen, MD, FRCPA, Leo I. Gordon, MD

Blood (2013) 122 (21): 1807.

https://doi.org/10.1182/blood.V122.21.1807.1807

Published: 2013

Journal Articles

A Multicenter Phase II Clinical Trial of Rituximab Combined with Bortezomib (VELCADE®) Therapy for Untreated “High Tumor Burden” Indolent Non-Hodgkin Lymphoma (NHL)

Andrew M. Evens, DO, MSc, Mitchell R Smith, MD, PhD, Izidore S Lossos, MD, Borko Jovanovic, PhD, Adam Cohen, MD, Jane N. Winter, MD, Steven T. Rosen, MD, FRCPA, Leo I. Gordon, MD

Blood (2012) 120 (21): 1642.

https://doi.org/10.1182/blood.V120.21.1642.1642

Published: 2012

Journal Articles

Multiple Myeloma Associated GI Polyposis

Nassim Nabbout, MD, Mohamad El Hawari, MD, Thomas K. Schulz, MD

Blood (2012) 120 (21): 5009.

https://doi.org/10.1182/blood.V120.21.5009.5009

Published: 2012

Journal Articles

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

Fabrizio Foieni, MD, Andrea Zanichelli, MD, Anna Coerezza, MD, Roberto Castelli, MD, Lorena Maggioni, PhD, Chiara Suffritti, PhD, Erika Bonanni, Augusto B. Federici, MD, Marco Cicardi, MD

Blood (2011) 118 (21): 1596.

https://doi.org/10.1182/blood.V118.21.1596.1596

Published: 2011

Journal Articles

Update of An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)

Pierre Fenaux, MD, PhD, Hagop M. Kantarjian, Petra Muus, MD, PhD, Roger M. Lyons, MD, Richard A. Larson, MD, Mikkael A. Sekeres, MD, MS, Pamela S. Becker, MD, PhD, Catherine Jia, PhD, Allen S. Yang, MD, PhD

Blood (2011) 118 (21): 2772.

https://doi.org/10.1182/blood.V118.21.2772.2772

Published: 2011

Journal Articles

Efficacy of Bortezomib/Cyclophosphamide/Dexamethasone (VCD) Chemotherapy In Naive Patients with High Risk Cardiac Light Chain Amyloidosis (Mayo Clinic stage III)

Arnaud Jaccard, Murielle Roussel, Anne Banos, David Lavergne, Jacques Ninet, Bertrand Arnulf, MD, PhD, Dominique Bordessoule, Frank Bridoux, Jean Paul Fermand, MD

Blood (2011) 118 (21): 5126.

https://doi.org/10.1182/blood.V118.21.5126.5126

Published: 2011

Journal Articles

Pediatric-Like Intensified Therapy In Adult Acute Lymphoblastic Leukemia: A Single Centre Experience

Sarah Parisi, Stefania Paolini, Ilaria Iacobucci, PhD, Cristina Papayannidis, Mariachiara Abbenante, Antonio Curti, MD, Emanuela Ottaviani, Nicoletta Testoni, Michele Baccarani, MD, Giovanni Martinelli, MD, PhD

Blood (2011) 118 (21): 4261.

https://doi.org/10.1182/blood.V118.21.4261.4261

Published: 2011

Journal Articles

Sequential Therapy with Activated Prothrombin Complex Concentrates and Recombinant Factor VIIa in the Treatment of Unresponsive Bleeding in Patients with Hemophilia and Inhibitors

Young shil Park, M.D., Yong-Mook Choi, M.D., Ji Kyoung Park, M.D.

Blood (2011) 118 (21): 4664.

https://doi.org/10.1182/blood.V118.21.4664.4664

Published: 2011

Journal Articles

Efficacy and Safety of Nilotinib In Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (Pts) with Type 2 Diabetes In the ENESTnd Trial.

Giuseppe Saglio, MD, PhD, Richard A. Larson, MD, Timothy P. Hughes, MD, MBBS, Surapol Issaragrisil, MD, Anna G. Turkina, MD, PhD, David Marin, MD, FRCP, Maria Zanichelli, MD, Hirohiko Shibayama, MD, PhD, Matt E. Kalaycio, MD, Francoise Rigal-Huguet, MD, Neil J. Gallagher, MD, PhD, Marcia Kayath, MD, Ming Zheng, PhD, Hagop Kantarjian, MD, Andreas Hochhaus, MD

Blood (2010) 116 (21): 3430.

https://doi.org/10.1182/blood.V116.21.3430.3430

Published: 2010

Journal Articles

High Rate of Complete Remission (CR) and Upgraded Response with Weekly Maintenance Bortezomib Post Single Autologous Peripheral Stem Cell Transplant (PSCT) In Patients with Multiple Myeloma. Results of a Phase II Prospective Study

Firoozeh Sahebi, M.D., Amrita Krishnan, M.D., Leonardo Farol, MD, Ji-Lian Cai, MD, George Somlo, MD, Leslie Popplewell, M.D., R. Spielberger, M.D., Neil Martin Kogut, MD, Chatchada Karanes, MD, Christopher Ruel, Paul Frankel, Eunicia Reburiano, Margret O'Donnell, MD, Stephen Forman

Blood (2010) 116 (21): 2399.

https://doi.org/10.1182/blood.V116.21.2399.2399

Published: 2010

Journal Articles

Pediatric Therapy In Adult Acute Lymphoblastic Leukemia: Updated Experience of a Single Centre

Stefania Paolini, Sarah Parisi, Ilaria Iacobucci, Cristina Papayannidis, Maria Chiara Abbenante, Antonio Curti, Emanuela Ottaviani, Nicoletta Testoni, Michele Baccarani, Giovanni Martinelli

Blood (2010) 116 (21): 4338.

https://doi.org/10.1182/blood.V116.21.4338.4338

Published: 2010

Journal Articles

Causes of Death for Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Treated with Imatinib.

Andrea Renata Dean, MD, Hagop M. Kantarjian, MD, Susan O'Brien, MD, Mary Beth Rios, Alfonso Quintas-Cardama, MD, Elias Jabbour, MD, Jianqin Shan, Ph.D, Jorge Cortes, MD

Blood (2009) 114 (22): 4279.

https://doi.org/10.1182/blood.V114.22.4279.4279

Published: 2009

NARROW

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

Safety and Tolerability of PF-04447943 across a Clinical Trial Program Including 277 Patients

A Prospective Study to Evaluate the Efficacy, Safety and Response Duration of Newly Diagnosed Adult Immune Thrombocytopenia Patients Treated with Low Dose Rituximab and High Dose of Dexamethasone

Clinical Characteristics of Philadelphia Positive T-Cell Lymphoid Leukemias - (de novo and blast phase CML)

Nilotinib Combined with Multi-Agents Chemotherapy for Adult Patients with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of a Prospective Study from a Single Center

Safety and Clinical Activity of Atezolizumab (Anti-PDL1) in Combination with Obinutuzumab in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma

FEIBA™ for Patients on Direct Oral Anticoagulants Requiring Urgent Surgery

Intraperitoneal Administration Of Activated Protein C Prevents Post-Surgical Adhesion Band Formation

A Multicenter Phase II Study Of Bortezomib (VELCADE®) Combined With Rituximab For Untreated High Tumor Burden (HTB) Indolent Non-Hodgkin Lymphoma (NHL): Long-Term Follow-Up Of Outcomes and Examination Of Prognostic Factors

A Multicenter Phase II Clinical Trial of Rituximab Combined with Bortezomib (VELCADE®) Therapy for Untreated “High Tumor Burden” Indolent Non-Hodgkin Lymphoma (NHL)

Multiple Myeloma Associated GI Polyposis

Lymphoproliferative Disorder and Acquired C1-INH Deficiency. A Case Series of 48 Patients

Update of An Open-Label Extension Study Evaluating the Long-Term Safety and Efficacy of Romiplostim in Thrombocytopenic Patients with Myelodysplastic Syndromes (MDS)

Efficacy of Bortezomib/Cyclophosphamide/Dexamethasone (VCD) Chemotherapy In Naive Patients with High Risk Cardiac Light Chain Amyloidosis (Mayo Clinic stage III)

Pediatric-Like Intensified Therapy In Adult Acute Lymphoblastic Leukemia: A Single Centre Experience

Sequential Therapy with Activated Prothrombin Complex Concentrates and Recombinant Factor VIIa in the Treatment of Unresponsive Bleeding in Patients with Hemophilia and Inhibitors

Efficacy and Safety of Nilotinib In Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (Pts) with Type 2 Diabetes In the ENESTnd Trial.

High Rate of Complete Remission (CR) and Upgraded Response with Weekly Maintenance Bortezomib Post Single Autologous Peripheral Stem Cell Transplant (PSCT) In Patients with Multiple Myeloma. Results of a Phase II Prospective Study

Pediatric Therapy In Adult Acute Lymphoblastic Leukemia: Updated Experience of a Single Centre

Causes of Death for Patients with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Treated with Imatinib.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only